Get all your news in one place.
100’s of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100’s of premium titles. One news app.
The Latest Breaking News on After US approval, Japan OKs its first Alzheimer's drug. Leqembi was developed by Eisai and Biogen
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Get all your
news in one place.
news in one place.
100’s of premium titles.
One news app.
One news app.
Get all your
news in one place.
news in one place.
100’s of premium titles.
One news app.
One news app.
People
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Organisations
NHS
22,327 stories
FDA
5,329 stories
Salon
2,116 stories
NHS England
1,541 stories
NICE
1,100 stories
Eli Lilly
808 stories
UCL
446 stories
CMS
399 stories
Lilly
387 stories
KFF
301 stories
Biogen
270 stories
Alzheimer Society
214 stories
the Food and Drug Administration
182 stories
Alzheimer Research UK
130 stories
Eisai
95 stories
Biogen Inc
87 stories
Eli Lilly and Company
53 stories
JAMA
36 stories
the Alzheimer Association
35 stories
Leqembi
23 stories
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Topics